Top compounds associated with response to RNFT2


Feature Type Standardized
Nominal ANOVA
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.14 0.0002
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.14 0.0002
mRNA ouabain CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA bid1870 gCSI pan-cancer AAC -0.21 0.0003
mRNA parbendazole CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA methylstat CTRPv2 pan-cancer AAC 0.16 0.0003
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
Download CSV